Stephens & Co. Reiterates Overweight on Encompass Health, Maintains $105 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel has reiterated an Overweight rating on Encompass Health (NYSE:EHC) and maintained a $105 price target.
August 06, 2024 | 3:41 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stephens & Co. analyst Scott Fidel has reiterated an Overweight rating on Encompass Health (NYSE:EHC) and maintained a $105 price target.
The reiteration of an Overweight rating and a maintained price target of $105 by a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100